Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
Boehringer Ingelheim is developing a new biologicals development centre (BDC) within its Biberach plant site in Germany.
Modular Pharmaceutical and Biopharmaceutical Production Facilities
DanviksCenter 28,
SE,
Nacka,
13130 Other,
Sweden
Pharmadule offers the fastest and most profitable way to implement a pharmaceutical or biopharmaceutical production facility. With close to 20 years’ experience and about 60 successful project implementations around the world, our knowledge of the industry is unmatched.
Among our customers are many of the world’s major pharmaceutical companies. Our staff are dedicated professionals with direct experience of the pharmaceutical industry. Between them, they have over 650 years’ experience in design, operations, development, project management, maintenance and validation.
Our areas of expertise are:
Our additional value services include:
Pharmadule is committed to giving your business a competitive edge. Our extensive skills and experience ensure the project is a smooth, precision operation that delivers top-quality results – on time and to budget. We are with you from the start of your project until your facility is up and running.
Pharmadule focuses on the critical elements of a pharmaceutical plant. We coordinate all activities and take full responsibility the whole project, guaranteeing that your plant begins production on schedule. Process engineering, architectural design, civil construction, and commissioning and qualification are all developed and fully integrated in parallel with ground preparation and construction.
We understand that time-to-market is crucial to the success of a drug, and our whole process is geared to getting your plant into production faster. Speed gives important financial benefits: Pharmadule’s solutions enable you to generate income much earlier and move into new markets more quickly, saving 6-12 months on most projects.
Pharmadule’s fast project implementation also allows you to defer your decision until you’re truly ready. Your will still be able to get to market on time.
Pharmadule’s delivery and start-up times are the fastest in the industry. Schedules are compressed by running activities in parallel. Site preparations take place while the facility is being fabricated in Sweden. Part of the qualification procedure is performed in Sweden prior to delivery, which leads to shorter on-site validation and involves fewer people.
Pharmadule’s predictable methods enable us to guarantee the price and the date when your facility will be delivered. We work to a fixed price with a defined cash flow and schedule, assuring that your business requirements will be met.
Working with Pharmadule means you deal with one partner, avoiding the hassle of coordinating numerous subcontractors, consultants and construction companies. This makes the whole project easier, more effective and more economical. Cost overruns, time delays and technical difficulties typically associated with traditional construction are minimised.
A Pharmadule facility can easily be expanded so you can keep the initial investment to a minimum and then grow with the demand. In the event of changing market or business conditions, the Pharmadule facility can also be relocated. Standardisation ensures that expansion or relocation proceeds quickly and effectively.
Modular fabrication minimises risks as the facilities are fabricated in a controlled workshop environment. Fabrication is standardised and rationalised in an assembly line manner. Pre-qualification testing and customer inspection of the facilities are completed before shipment to assure compliance to the agreed specifications. Final commissioning and qualification (IQ and OQ) are carried out after reassembly at the client’s site.
Our facilities comply with cGMP requirements and can be designed to meet Biological Safety Levels (BSL) and High Potency Containment (HPC) as required.
Working with Pharmadule means you deal with one partner. This makes the whole project easier, more effective and more economical.
Boehringer Ingelheim is developing a new biologicals development centre (BDC) within its Biberach plant site in Germany.
Brazilian pharmaceutical firm Biolab Farmacêutica has opened a new research and development (R&D) centre in Mississauga in the Greater Toronto Area (GTA) of Ontario, Canada.
German pharmaceutical firm Fresenius Kabi is expanding its pharmaceutical manufacturing facility in Wilson, North Carolina.
Start-up pharmaceutical company Oxford Pharmaceuticals broke ground for the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama, US, in September 2015.
In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re
Merck's 272,000ft² vaccine production plant is located on a 262-acre site in Treyburn Corporate Park on the north s
In April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico
Merck Sharpe & Dohme, known as MSD Technology Singapore Pte Ltd in Singapore, opened their newest manufacturing facility
Baxter BioPharma Solutions is a contract manufacturer of pre-filled syringes, vials and cartridges for the packaging of vaccines and drugs to treat chronic conditions such as rheumatoid arthritis and multiple sclerosis.
In 2000, Nycomed Amersham announced it would open a new pharmaceutical plant in Shanghai on 27 October.
DanviksCenter 28
SE
Nacka
13130
Other
Sweden
Arendals Allé, ARX
PO Box 8744
SE - 402 75 Gothenburg
Other
Sweden
500 Hills Drive, STE 120
NJ 07921
Bedminster
Other
United States of America